Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-19

Clinical Trial Update: Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers [NA]

View source ↗

Summary

A clinical trial evaluating the NEURODIGITX app-delivered deep breathing for anxiety and quality of life in caregivers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Anxiety Disorders, Hospital Workers | NA | Status: WITHDRAWN